← Leaderboards
Yuri Fedoriw
Univ Of North Carolina Chapel Hill
$2,581,863
Attributed
$3,253,216
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,323,731 · 5
By mechanism
U54$7,636,821 · 3
D43$1,342,707 · 1
R21$344,203 · 1
Top collaborators
- Blossom A Damania8 shared
- Carla J Chibwesha7 shared
- Dirk P Dittmer7 shared
- Paul Ruff7 shared
- Lameck Chinula5 shared
- Jacqueline Huwa4 shared
- Hannock Mukoma Tweya3 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Dirk P Dittmer$32,603,888
- Satish Gopal$2,413,535
- Carla J Chibwesha$4,372,568
- Jeremy R Wang$1,462,885
- Katherine Douglas Westmoreland$768,155
Others in their field
Other Emerging Leaders on “Malawi”
- Michael Levin · Imperial College Of Science, Technology And Medicine$4,954,718
- Alfred Matengeni · Michigan State University$3,450,475
- Melissa Gladstone · University Of Maryland Baltimore$3,242,981
- Kazione Kulisewa · Univ Of North Carolina Chapel Hill$2,727,435
- Joseph Carson · Pensievision, Inc.$2,158,876
- Corrina Moucheraud · University Of California Los Angeles$2,123,527
Research focus
MalawiLymphomaMalignant Neoplasm Of Cervix UteriAfrica South Of The SaharaMalignant NeoplasmsUniversitiesCollaborationsTranslational ResearchCountryAids Related CancerScreeningSiteKaposi SarcomaClinical ResearchHospitalsInnovationResearch Project GrantsInfrastructureSouth AfricaInstitutionResearch PersonnelEnsurePrognosisMolecular
Grant awards (24)
Innovations in Molecular Diagnostic Approaches for HIV-associated Lymphomas.$344,203
R21 · FY2025 · TW · contact PI
Malawi Cancer Outcomes Research Program (M-CORP)$268,228
D43 · FY2025 · CA · contact PI
Innovations for screening and prognosis in HIV+ cancers including Kaposi sarcoma, cervical cancer, and lymphoma in Malawi and South Africa$1,094,228
U54 · FY2024 · CA
Malawi Cancer Outcomes Research Program (M-CORP)$268,261
D43 · FY2024 · CA · contact PI
Project 3: Tumor-associated biomarkers for HIV-associated Diffuse Large B-cell Lymphoma in Malawi and South Africa$233,557
U54 · FY2024 · CA · contact PI
Pathology Core$74,053
U54 · FY2024 · CA · contact PI
Innovations for screening and prognosis in HIV+ cancers including Kaposi sarcoma, cervical cancer, and lymphoma in Malawi and South Africa$1,097,066
U54 · FY2023 · CA
Malawi Cancer Outcomes Research Program (M-CORP)$268,334
D43 · FY2023 · CA · contact PI
Project 3: Tumor-associated biomarkers for HIV-associated Diffuse Large B-cell Lymphoma in Malawi and South Africa$233,558
U54 · FY2023 · CA · contact PI
Supplement: The Association Between Stigma and Wellbeing among Kaposi sarcoma and Lymphoma Patients in Malawi$172,245
U54 · FY2023 · CA
Pathology Core$74,461
U54 · FY2023 · CA · contact PI
Innovations for screening and prognosis in HIV+ cancers including Kaposi sarcoma, cervical cancer, and lymphoma in Malawi and South Africa$1,101,859
U54 · FY2022 · CA
Malawi Cancer Outcomes Research Program (M-CORP)$268,912
D43 · FY2022 · CA · contact PI
Project 3: Tumor-associated biomarkers for HIV-associated Diffuse Large B-cell Lymphoma in Malawi and South Africa$233,320
U54 · FY2022 · CA · contact PI
Performance of different sample types for high-risk human papillomavirus testing and genotyping for the detection of high grade cervical intraepithelial neoplasia$125,000
U54 · FY2022 · CA
Pathology Core$74,880
U54 · FY2022 · CA · contact PI
Innovations for screening and prognosis in HIV+ cancers including Kaposi sarcoma, cervical cancer, and lymphoma in Malawi and South Africa$1,109,032
U54 · FY2021 · CA
Malawi Cancer Outcomes Research Program (M-CORP)$268,972
D43 · FY2021 · CA · contact PI
Project 3: Tumor-associated biomarkers for HIV-associated Diffuse Large B-cell Lymphoma in Malawi and South Africa$232,369
U54 · FY2021 · CA · contact PI
The road to recovery: An assessment of patient-reported quality of life among cancer survivors in Malawi.$190,625
U54 · FY2021 · CA
Pathology Core$80,905
U54 · FY2021 · CA · contact PI
Innovations for screening and prognosis in HIV+ cancers including Kaposi sarcoma, cervical cancer, and lymphoma in Malawi and South Africa$1,180,460
U54 · FY2020 · CA
Project 3: Tumor-associated biomarkers for HIV-associated Diffuse Large B-cell Lymphoma in Malawi and South Africa$247,670
U54 · FY2020 · CA · contact PI
Pathology Core$81,533
U54 · FY2020 · CA · contact PI